Reasons for preference of growth factor mobilized peripheral blood stem cells for high dose chemotherapy/hematopoietic stem cell transplantation (HDC/HSCT) in Hodgkin’s lymphoma.
Ease of procurement
Avoidance of general anesthesia
Avoidance of hospitalization for stem cell collection
More rapid neutrophil and platelet recovery
Lower net cost of procurement
Lower net cost of transplant hospitalization due to more rapid engraftment
Applicability for patients with prior pelvic irradiation or prior or current bone marrow involvement
Ease of procurement
Avoidance of general anesthesia
Avoidance of hospitalization for stem cell collection
More rapid neutrophil and platelet recovery
Lower net cost of procurement
Lower net cost of transplant hospitalization due to more rapid engraftment
Applicability for patients with prior pelvic irradiation or prior or current bone marrow involvement